Cargando…

Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence

This review is focused on discussing in some detail possible neuroprotective functions of microglial cells. We strive to explain how loss of these essential microglial functions might contribute toward the development of characteristic neuropathological features that characterize Alzheimer’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Streit, Wolfgang J., Xue, Qing-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398410/
https://www.ncbi.nlm.nih.gov/pubmed/22822399
http://dx.doi.org/10.3389/fphar.2012.00138
_version_ 1782238283333369856
author Streit, Wolfgang J.
Xue, Qing-Shan
author_facet Streit, Wolfgang J.
Xue, Qing-Shan
author_sort Streit, Wolfgang J.
collection PubMed
description This review is focused on discussing in some detail possible neuroprotective functions of microglial cells. We strive to explain how loss of these essential microglial functions might contribute toward the development of characteristic neuropathological features that characterize Alzheimer’s disease. The conceptual framework guiding our thinking is provided by the hypothesis that microglial senescence accounts for impaired neuronal protection and consequent neurodegeneration.
format Online
Article
Text
id pubmed-3398410
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33984102012-07-20 Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence Streit, Wolfgang J. Xue, Qing-Shan Front Pharmacol Pharmacology This review is focused on discussing in some detail possible neuroprotective functions of microglial cells. We strive to explain how loss of these essential microglial functions might contribute toward the development of characteristic neuropathological features that characterize Alzheimer’s disease. The conceptual framework guiding our thinking is provided by the hypothesis that microglial senescence accounts for impaired neuronal protection and consequent neurodegeneration. Frontiers Research Foundation 2012-07-17 /pmc/articles/PMC3398410/ /pubmed/22822399 http://dx.doi.org/10.3389/fphar.2012.00138 Text en Copyright © 2012 Streit and Xue. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Pharmacology
Streit, Wolfgang J.
Xue, Qing-Shan
Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title_full Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title_fullStr Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title_full_unstemmed Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title_short Alzheimer’s Disease, Neuroprotection, and CNS Immunosenescence
title_sort alzheimer’s disease, neuroprotection, and cns immunosenescence
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398410/
https://www.ncbi.nlm.nih.gov/pubmed/22822399
http://dx.doi.org/10.3389/fphar.2012.00138
work_keys_str_mv AT streitwolfgangj alzheimersdiseaseneuroprotectionandcnsimmunosenescence
AT xueqingshan alzheimersdiseaseneuroprotectionandcnsimmunosenescence